News & Events
Early Discharge After Lung Surgery Benefits Patients Without Raising Readmission Risk
When hospitals implement programs to optimize patients’ recovery from surgery, healthcare costs fall and patients show improved outcomes. One major benefit of the programs—known as enhanced recovery pathways—include shorter hospital stays.
Undernutrition During Pregnancy Changes Lung-Specific Gene Expression
Jefferson researchers found how a mother’s diet can affect epigenetic markers of her children and result in changes to genes that regulate lung health.
How to Reduce Implicit Bias in Emergency Medical Care
Jefferson researchers collaborated with researchers at the University of Pennsylvania on a training program for emergency medicine residents and tested how well it worked.
Potential Treatment for Cancer in Butterfly Disease
An international team of scientists have identified a potential drug treatment for patients with epidermolysis bullosa, or butterfly disease.
Thomas Jefferson University Launches Nation’s First Academic Department of Integrative Medicine
Jefferson (Philadelphia University + Thomas Jefferson University) has established a Department of Integrative Medicine and Nutritional Sciences, the first of its kind in academic medicine.
A Battle Fought in the Brain
Jefferson researchers explored whether it is possible to build up immunity in the central nervous system.
New Role for Death Molecule
Jefferson researchers examined a molecule that is considered unimportant in order to shed new light on the regulation of cell death and survival.
How Fibrosis Develops in Butterfly Syndrome Patients
Jefferson researchers discover potential therapy for major disease symptom.
Effective Method for Reducing Hospital Stay After Whipple Operation
Jefferson researchers found that the five-day Whipple accelerated recovery pathway (WARP) reduced patients' length of stay without significantly increasing complication rates.
Blocking Toxic-Protein Production in ALS
An approved drug that blocks an integrated stress response shows promise in preliminary tests against ALS and frontotemporal dementia.